Karen Frank, chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center, has been appointed Peter A. Nickerson, PhD, Professor and Endowed Chair of Pathology ...

For centuries, the field of pathology has been defined by a single instrument: the microscope. But according to William ...

A Lee County judge has thrown out the conviction of Brooke Shoemaker, who has spent the past five years in prison after being ...

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Detailed price information for Fulgent Genetics Inc (FLGT-Q) from The Globe and Mail including charting and trades.

NEW YORK – Fulgent Genetics announced on Monday that it has entered into a definitive agreement to acquire lab service provider StrataDx, as well as certain assets of Bako Diagnostics. Fulgent said it ...

Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services.

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Frank has been chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center since 2018.